首页 | 本学科首页   官方微博 | 高级检索  
     

异烟肼对利福平单耐/多耐药肺结核患者治疗效果的分析
引用本文:代晓琦,李仁忠,阮云洲,苏伟,王忠东,王黎霞. 异烟肼对利福平单耐/多耐药肺结核患者治疗效果的分析[J]. 中国防痨杂志, 2018, 40(6): 564-569. DOI: 10.3969/j.issn.1000-6621.2018.06.004
作者姓名:代晓琦  李仁忠  阮云洲  苏伟  王忠东  王黎霞
作者单位:中国疾病预防控制中心结核病预防控制中心(李仁忠、阮云洲、苏伟、王黎霞)
基金项目:中国国家卫生和计划生育委员会-盖茨基金会结核病防治合作项目(51914)
摘    要: 目的 分析异烟肼对患者的治疗效果,为有效治疗和预防控制利福平单耐/多耐药肺结核提供参考依据。

关 键 词:结核    异烟肼  结核  抗多种药物性  治疗结果  疗效比较研究  
收稿时间:2018-03-12

Analysis on effects of isoniazid treatment in patients with rifampicin mono-/poly-drug-resistant tuberculosis
Xiao-qi DAI,Ren-zhong LI,Yun-zhou RUAN,Wei SU,Zhong-dong WANG,Li-xia. WANG. Analysis on effects of isoniazid treatment in patients with rifampicin mono-/poly-drug-resistant tuberculosis[J]. The Journal of The Chinese Antituberculosis Association, 2018, 40(6): 564-569. DOI: 10.3969/j.issn.1000-6621.2018.06.004
Authors:Xiao-qi DAI  Ren-zhong LI  Yun-zhou RUAN  Wei SU  Zhong-dong WANG  Li-xia. WANG
Affiliation:Tuberculosis Control Division of Qingdao Municipal Center for Disease Control and Prevention, Qingdao Institute of Preventive Medicine, Qingdao 266033, China
Abstract: Objective To analyze the therapeutic effects of isoniazid for the patients with rifampicin mono-resistant tuberculosis (RMR-TB) and rifampicin poly-drug-resistant tuberculosis (RPR-TB), and to provide re-ference basis for developing the effective treatments as well as the prevention and control measures to those patients.
Keywords:Tuberculosis  pulmonary  Isoniazide  Tuberculosis  multidrug-resistant  Treatment outcome  Comparative effectiveness research  
点击此处可从《中国防痨杂志》浏览原始摘要信息
点击此处可从《中国防痨杂志》下载全文
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号